awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q58736005
Q58736005
Item
http://www.wikidata.org/entity/Q58736005
Q58736005
about
Q58736005
Item
http://www.wikidata.org/entity/Q58736005
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2018
@uk
type
Item
P1433
Q58736005-8CBA6CC4-F195-4138-A1CC-A9B78E97E6FA
P2093
Q58736005-22A36971-B3FE-46F0-9093-72FA032F42EB
Q58736005-A8D369EA-FB14-425D-819F-6DAA5338B8E6
P2860
Q58736005-02DDC6D1-F8C3-4E1C-BB9B-B3D3BA094DA3
Q58736005-0302EDBB-2851-4A5B-B88A-C6D7886C7EC6
Q58736005-05F8F693-5678-4D73-A9DF-BEFCF73E7EB4
Q58736005-076C393F-D61D-4250-A911-4B9AE8DAC38D
Q58736005-0A09511C-DABB-4BB9-910D-91BA542A3AEC
Q58736005-0FE1BCC1-56AC-4FC4-A686-C6E529B15823
Q58736005-16D613DE-90D8-461C-A941-52E08C1A933A
Q58736005-197A5C7B-AC31-4031-A566-64F57E067B8A
Q58736005-21A32B9D-E1CD-4DAA-8751-124421868183
Q58736005-3DD86144-60F8-4261-BF95-C562DE5553D3
Show more
P304
Q58736005-A3AC6F10-6434-44BB-9AF9-BD5CCFA5CC4B
P31
Q58736005-EC8A9BDC-CDA5-4569-82AD-245E6D0364D2
P356
Q58736005-80DDAEA1-51ED-4213-81CF-2039319259DF
P433
Q58736005-6E4B8579-5763-4FEE-8FFA-73686DEAC20F
P478
Q58736005-98FEF5A0-5FF0-4573-B35F-0C76D28201C5
P577
Q58736005-555D96E0-C0F8-4E1D-BC6E-6E05E39A5C28
P698
Q58736005-C4DBE436-15C5-4B04-99AE-40D91CD2C35E
P932
Q58736005-F7FB1431-2FF8-408F-903B-0DAA027924F8
P356
J.ISSN.1009-3419.2018.08.10
P1433
Zhongguo fei ai za zhi
P2093
Diansheng Zhong
http://www.w3.org/2001/XMLSchema#string
Xia Liu
http://www.w3.org/2001/XMLSchema#string
P2860
Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations.
Oncogenic BRAF Deletions That Function as Homodimers and Are Sensitive to Inhibition by RAF Dimer Inhibitor LY3009120.
Comprehensive molecular profiling of lung adenocarcinoma.
Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF
Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing
A meta-analysis of the association between BRAF mutation and nonsmall cell lung cancer
Coexistence of EGFR with KRAS, or BRAF, or PIK3CA somatic mutations in lung cancer: a comprehensive mutation profiling from 5125 Chinese cohorts.
Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium.
BRAF mutations in non-small cell lung cancer.
Show more
P304
635-640
http://www.w3.org/2001/XMLSchema#string
P31
scholarly article
P356
10.3779/J.ISSN.1009-3419.2018.08.10
http://www.w3.org/2001/XMLSchema#string
P433
8
http://www.w3.org/2001/XMLSchema#string
P478
21
http://www.w3.org/2001/XMLSchema#string
P577
2018-08-20T00:00:00Z
http://www.w3.org/2001/XMLSchema#dateTime
P698
30172272
http://www.w3.org/2001/XMLSchema#string
P932
6105358
http://www.w3.org/2001/XMLSchema#string